Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

AHMET CİNGÖZ

Doktor Öğretim Üyesi

Bezm-İ Âlem Vakıf Üniversitesi Yaşam Bilimleri Ve Biyoteknoloji Enstitüsü Moleküler Biyoloji Anabilim Dalı

Research topics OpenAlex
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Tıbbi Biyoloji
Articles 23 YÖKSİS 23 · OpenAlex 0 Total citations 505 h-index 13 · OpenAlex Q1 articles 14 Scopus · WoS Q1 11 Best field rank #13,816 / 39,749 Main field · top 34.8% Co-authors 129 6 Turkish institutions

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 23
h-index 13 Percentile in Türkiye: 91 #53 of 318 at their university by h-index
i10-index
15
Total citations
505
Top 11% in Türkiye
Per article
22.0
FWCI
1.77
1.00 = world average
World top 1%
0
World top 10%
3

Most cited articles

  1. Identification of SERPINE1 as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling 2019 world top 10% 87 citations
  2. Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer 2020 world top 10% 50 citations
  3. The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme 2019 47 citations
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
129
With an akaturk profile
23
Turkish institutions
6
Co-authored works
%100

Academic co-authors 23

  1. TUĞBA BAĞCI ÖNDER Profesör · Koç Üniversitesi 22
  2. NATHAN ALLAN LACK Doçent · Koç Üniversitesi 10
  3. TEVFİK TAMER ÖNDER Profesör · Koç Üniversitesi 7
  4. CEYDA AÇILAN AYHAN Profesör · Koç Üniversitesi 5
  5. ALİŞAN KAYABÖLEN Doktor Öğretim Üyesi · Koç Üniversitesi 4
  6. İHSAN SOLAROĞLU Profesör · Koç Üniversitesi 4
  7. MEHMET GÖNEN Profesör · Koç Üniversitesi 3
  8. İBRAHİM KULAÇ Doçent · Koç Üniversitesi 3
  9. BUSE CEVATEMRE YILDIRIM Öğretim Görevlisi (uygulamalı Birim) · Koç Üniversitesi 2
  10. NURCAN TUNÇBAĞ Doçent · Koç Üniversitesi 2
Show all (23)
  1. SEDA KIZILEL Profesör · Koç Üniversitesi 2
  2. SERÇİN KARAHÜSEYİNOĞLU Doktor Öğretim Üyesi · Koç Üniversitesi 2
  3. BENAY UZER YILMAZ Doktor Öğretim Üyesi · İzmir Yüksek Teknoloji Enstitüsü 1
  4. DEMİRCAN CANADİNÇ Profesör · Koç Üniversitesi 1
  5. HALİL BAYRAKTAR Profesör · İstanbul Teknik Üniversitesi 1
  6. HANDE GÜNDÜZ KOÇAN Öğretim Görevlisi (ders Vermekle Görevli) · Koç Üniversitesi 1
  7. MEHMET BATU ERMAN Profesör · Acıbadem Mehmet Ali Aydınlar Üniversitesi 1
  8. MEHMET KAHRAMAN Profesör · Gaziantep Üniversitesi 1
  9. METİN SİTTİ Profesör · Koç Üniversitesi 1
  10. SAFACAN KÖLEMEN Doçent · Koç Üniversitesi 1
  11. SAFİYE ÇAVDAR Profesör · Koç Üniversitesi 1
  12. SIDIKA MİNE TOKER Doçent · Eskişehir Osmangazi Üniversitesi 1
  13. İLKE ALİ GÜRSES Profesör · Koç Üniversitesi 1

National collaboration 6 institutions

  1. Koç Üniversitesi 23 works · 18 academics
  2. Acıbadem Mehmet Ali Aydınlar Üniversitesi 1 works · 1 academics
  3. Eskişehir Osmangazi Üniversitesi 1 works · 1 academics
  4. Gaziantep Üniversitesi 1 works · 1 academics
  5. İstanbul Teknik Üniversitesi 1 works · 1 academics
  6. İzmir Yüksek Teknoloji Enstitüsü 1 works · 1 academics

Other co-authors (incl. international) 106

Ali Cenk Aksu 7Fidan Seker-Polat 7Tunç Morova 7Adam Cribbs 5Filiz Senbabaoglu 5HAMZAH SYED 5Ayşe Derya Cavga 4EZGİ ÖZYERLİ GÖKNAR 4Ezgi Yağmur Kala 4M Philpott 4ÖZLEM YEDİER BAYRAM 4İlknur Sur-Erdem 4Ebru Yılmaz 3Fidan Şeker 3Fırat Uyulur 3Nareg Pınarbaşı-Değirmenci 3Udo Oppermann 3Zeynep Hülya Gümüş 3Beril Esin 2Betül Ersoy-Fazlıoğlu 2Beyza Dedeoğlu 2Can Aztekin 2Daniel P. Cahill 2Emirhan Tekoğlu 2Ezgi Kaya 2Gizem Nur Şahin 2HTM Timmers 2Hiroaki Wakimoto 2Ivan Pak Lok Yu 2PELİN ERKOÇ ERİK 2Selena Kazancioglu 2Selvan Myvizhi Esai 2Shreyas Lingadahalli 2Umut Berkay Altıntaş 2İpek Bulut 2AYŞE HÜMEYRA DUR KARASAYARAkane KawamuraAlp Can KaracakolAlp ErkentAlperen Acarı

Show all (106)

Altar OzbiyikAnıl KaplanArtem CherkasovBENGÜL GÖKBAYRAKBÜŞRA KÖSE ÖZKANColin CollinsDamlasu AltınözDeepak BhereEda KilicElisabete PiresErdem ErcanEsra Börklü-YücelEzgi Kaya-AksoyEzgi ÖzyerliG. GersteinGİZEM SÖYLERH. J. MaierHIZIR ASLIYÜKSEKHalit ÇakırHans AdomatHans AndomatHenry W. LongHilal SaraçIpek KokJames DunfordJames McCullaghKerem MusluKerim YavuzKevin XiaoKhalid ShahLadan FazliM BiniossekMartin GleaveMartin PhillpotMazhar ÖzkanMelike GezenMeriç DikbaşMichael Christoph HaffnerMine AltunbekMuhammad Anwaar NazeerMusa DirakMustafa ÇulhaNareg PınarbaşıNazife TolayNazlı ErgüderNihal Olcay DoğanOlka MissaghimamaghaniPaloma CejasRamiz GünsayS KungS NiuzamuddinSerdar Onur AydınSimge AcarSultan ÇetinToghrul AlmammadovTolga LokumcuUdo OppermanUgur Meric DikbasUğur BozüyükWilbert ZwartZeynep KahyaZeynep Kahya-YeşilZeynep KayaÖmer Duhan Toparlakİbrahim Çağrı Kurtİlknur Sur

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.

Indexes and citation percentiles

?
TR Index 0 articles
OpenAlex citation percentile
Top 1%0
Top 10%3
Avg · n 18 %80.5
Other counts

Scopus (SJR)

  • YÖKSİS rows 18

WoS (JCR)

  • YÖKSİS rows 18

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

23articles

Journals with publications

15 journals

Narrow down

Scopus (SJR)
Q114 Q23 Q31 Q40
WoS (JCR)
Q111 Q25 Q32 Q40
TR Index
0articles

Article list

  1. 2025 Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer Proceedings of the National Academy of Sciences DOI 10.1073/pnas.2500327122 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 92.5%
  2. 2025 Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer Experimental & Molecular Medicine DOI 10.1038/s12276-025-01466-5 YÖKSİS SJR Q1 JCR Q1 OpenAlex 83.1%
  3. 2025 Functional Genomic Screens Reveal RBBP4 as a Key Regulator of Cell Cycle Progression in TMZ-Resistant Glioblastoma bioRxiv DOI 10.1101/2025.05.09.653010 YÖKSİS
  4. 2024 Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer BioRxiv DOI 10.1101/2024.04.16.587277 YÖKSİS
  5. 2023 Lymphatic vessels accompanying dorsal and basal dural sinuses in the human brain Elsevier BV DOI 10.1016/j.jchemneu.2023.102357 YÖKSİS SJR Q3 JCR Q3 OpenAlex 78.4%
  6. 2023 Epigenetic-focused CRISPR/Cas9 screen identifies ASH2L as a regulator of glioblastoma cell survival bioRxiv DOI 10.1101/2022.08.17.504245 YÖKSİS
  7. 2023 Directing chemiluminescent dioxetanes to mitochondria: A cationic luminophore enables in vitro and in vivo detection of cancer cells upon enzymatic activation Sensors & Actuators: B. Chemical DOI 10.1016/j.snb.2023.133574 YÖKSİS SJR Q1 JCR Q1 OpenAlex 72.4%
  8. 2023 Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival Cell Commun Signal DOI 10.1186/s12964-023-01335-6 YÖKSİS SJR Q1 JCR Q1 OpenAlex 87.9%
  9. 2023 HOXB13 alters chromatin accessibility in prostate cancer through interactions with the SWI/SNF complex bioRxiv DOI 10.1101/2023.09.04.556101 YÖKSİS
  10. 2022 EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities Cell Death and Disease DOI 10.1038/s41419-022-05146-4 YÖKSİS SJR Q1 JCR Q1 OpenAlex 78.3%
  11. 2021 Parameters Influencing Gene Delivery Efficiency of PEGylated Chitosan Nanoparticles: Experimental and Modeling Approach Advanced NanoBiomed Research DOI 10.1002/anbr.202100033 YÖKSİS SJR Q1 JCR Q2 OpenAlex 79.1%
  12. 2021 Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization ONCOGENE DOI 10.1038/s41388-021-01697-6 YÖKSİS SJR Q1 JCR Q1 OpenAlex 65.6%
  13. 2020 Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma Frontiers in Neuroscience DOI 10.3389/fnins.2020.578316 YÖKSİS SJR Q2 JCR Q2 OpenAlex 47.6%
  14. 2020 Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer Oncogene DOI 10.1038/s41388-019-1116-8 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 92.2%
  15. 2020 TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway Neurological Research DOI 10.1080/01616412.2020.1796378 YÖKSİS SJR Q2 JCR Q3 OpenAlex 72.2%
  16. 2020 Combined inhibition of KDM6A/B and HDACs exacerbates integrated stress response and mediates therapeutic effects in IDH1-mutant glioma BioRxiv DOI 10.1101/2020.11.26.400234 YÖKSİS
  17. 2019 Identification of SERPINE1 as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling Cancers DOI https://www.mdpi.com/2072-6694/11/11/1651 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 95.2%
  18. 2019 The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme Cell Death Discovery DOI 10.1038/S41420-019-0144-Z YÖKSİS SJR Q2 JCR Q2 OpenAlex 87.1%
  19. 2019 The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma CELL DEATH DISEASE DOI 10.1038/s41419-019-2107-y YÖKSİS SJR Q1 JCR Q1 OpenAlex 88.2%
  20. 2017 KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL CELL DEATH DISEASE DOI 10.1038/cddis.2017.288 YÖKSİS SJR Q1 JCR Q1 OpenAlex 74.2%

← Back to academicians